Refine Results
  1. "JNCI
Formats
  1. Journal Article (351)
Groups
  1. Solid Tumor Oncology Division (111)
  2. Population Sciences Research Program (95)
  3. Epidemiology and Biostatistics (76)
  4. Survivorship Research (67)
  5. Surgery (59)
  6. Sloan Kettering Institute Faculty (48)

More Groups

People
  1. Larry Norton (18)
  2. Colin Begg (16)
  3. Kenneth Offit (15)
  4. Leonard Saltz (15)
  5. Carlos Cordon-Cardo (14)
  6. Mark Robson (13)

More People

Years
  1. 2020 (5)
  2. 2019 (15)
  3. 2018 (7)
  4. 2017 (11)
  5. 2016 (11)
  6. 2015 (18)

More Years

Publications
  1. JNCI: Journal of the National Cancer Institute (351)
Publishers
  1. Oxford University Press (351)

Results (351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating screening participation, follow-up, and outcomes for breast, cervical, and colorectal cancer in the PROSPR consortium
    Journal Article

    Barlow, W. E.; Beaber, E. F.; Geller, B. M.; Kamineni, A.; Zheng, Y.; Haas, J. S.; Chao, C. R.; Rutter, C. M.; Zauber, A. G.; Sprague, B. L.; more...
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Editorial - Breast cancer screening in high-risk women: Is MRI alone enough?
    Journal Article

    Rossi Saccarelli, C.; Bitencourt, A. G. V.; Morris, E. A.
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Sex-based disparities among cancer clinical trial participants
    Journal Article

    Ludmir, E. B.; Fuller, C. D.; Moningi, S.; Mainwaring, W.; Lin, T. A.; Miller, A. B.; Jethanandani, A.; Espinoza, A. F.; Verma, V.; Smith, B. D.; more...
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Evaluating clonal hematopoiesis in tumor-infiltrating leukocytes in breast cancer and secondary hematologic malignancies
    Journal Article

    Comen, E. A.; Bowman, R. L.; Selenica, P.; Kleppe, M.; Farnoud, N. R.; Pareja, F.; Weigelt, B.; Hill, C. E.; Alon, A.; Geyer, F. C.; more...
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade
    Journal Article

    Prat, A.; Pascual, T.; De Angelis, C.; Gutierrez, C.; Llombart-Cussac, A.; Wang, T.; Cortés, J.; Rexer, B.; Paré, L.; Forero, A.; more...
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: A randomized clinical trial
    Journal Article

    Garland, S. N.; Xie, S. X.; DuHamel, K.; Bao, T.; Li, Q.; Barg, F. K.; Song, S.; Kantoff, P.; Gehrman, P.; Mao, J. J.
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Measuring aging and identifying aging phenotypes in cancer survivors
    Journal Article

    Guida, J. L.; Ahles, T. A.; Belsky, D.; Campisi, J.; Cohen, H. J.; DeGregori, J.; Fuldner, R.; Ferrucci, L.; Gallicchio, L.; Gavrilov, L.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Patterns of cause-specific mortality among 2053 survivors of retinoblastoma, 1914-2016
    Journal Article

    Kleinerman, R. A.; Tucker, M. A.; Sigel, B. S.; Abramson, D. H.; Seddon, J. M.; Morton, L. M.
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Impact of sarcopenia on adverse outcomes after allogeneic hematopoietic cell transplantation
    Journal Article

    Armenian, S. H.; Xiao, M.; Teh, J. B.; Lee, B.; Chang, H. A.; Mascarenhas, K.; Lee, S.; Iukuridze, A.; Xie, J. J.; Scott, J. M.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Current treatment landscape of nasopharyngeal carcinoma and potential trials evaluating the value of immunotherapy
    Journal Article

    Le, Q. T.; Colevas, A. D.; O'Sullivan, B.; Lee, A. W. M.; Lee, N.; Ma, B.; Siu, L. L.; Waldron, J.; Lim, C. M.; Riaz, N.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save